Director sold ~$467K of Palantir
Scheduled in advanceTraded Oct 3, 2025 · Filed Oct 8, 2025
Sold under a plan set up in advance, so the timing wasn't a fresh decision
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$149,112
Shares × reported transaction price
60 days after results of Aug 4, 2025, 31 days before results of Nov 3, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $173.07 on Oct 3, 2025, 345% above its 52-week low and 7% below its high, after an 11% rise over the previous 30 trading days
52-week range $38.89 (Oct 7, 2024) to $187.05 (Oct 2, 2025), 91% of the way up, from 250 adjusted closes. 30 trading days earlier: $156.18 on Aug 21, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -2.1% | -1.2% | -1.0% |
| 30 days | -3.1% | -0.3% | -2.8% |
| 90 days | -2.1% | +2.8% | -4.9% |
| 180 days | -19.4% | -2.1% | -17.3% |
Past results only. Not a forecast.
Director sold ~$467K of Palantir
Scheduled in advanceDirector sold ~$1.26M of Palantir
Scheduled in advanceDirector sold ~$750K of Palantir
Scheduled in advance